These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 33247210)

  • 1. Nanomedicine and the COVID-19 vaccines.
    Nat Nanotechnol; 2020 Dec; 15(12):963. PubMed ID: 33247210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Messenger RNA vaccines against SARS-CoV-2.
    Topol EJ
    Cell; 2021 Mar; 184(6):1401. PubMed ID: 33740443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle-Mediated Cytoplasmic Delivery of Messenger RNA Vaccines: Challenges and Future Perspectives.
    Wu Z; Li T
    Pharm Res; 2021 Mar; 38(3):473-478. PubMed ID: 33660201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "When Will
    Bloom BR; Nowak GJ; Orenstein W
    N Engl J Med; 2020 Dec; 383(23):2202-2204. PubMed ID: 32897660
    [No Abstract]   [Full Text] [Related]  

  • 5. Why Oxford's positive COVID vaccine results are puzzling scientists.
    Callaway E
    Nature; 2020 Dec; 588(7836):16-18. PubMed ID: 33230278
    [No Abstract]   [Full Text] [Related]  

  • 6. How to redesign COVID vaccines so they protect against variants.
    Callaway E; Ledford H
    Nature; 2021 Feb; 590(7844):15-16. PubMed ID: 33514888
    [No Abstract]   [Full Text] [Related]  

  • 7. mRNA Vaccines: Possible Tools to Combat SARS-CoV-2.
    Yi C; Yi Y; Li J
    Virol Sin; 2020 Jun; 35(3):259-262. PubMed ID: 32524253
    [No Abstract]   [Full Text] [Related]  

  • 8. Novavax offers first evidence that COVID vaccines protect people against variants.
    Callaway E; Mallapaty S
    Nature; 2021 Feb; 590(7844):17. PubMed ID: 33510489
    [No Abstract]   [Full Text] [Related]  

  • 9. Nanotechnology versus coronavirus.
    Nat Nanotechnol; 2020 Aug; 15(8):617. PubMed ID: 32764720
    [No Abstract]   [Full Text] [Related]  

  • 10. It's time to consider a patent reprieve for COVID vaccines.
    Nature; 2021 Apr; 592(7852):7. PubMed ID: 33785920
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaccine wagers on coronavirus surface protein pay off.
    Cohen J
    Science; 2020 Nov; 370(6519):894-895. PubMed ID: 33214255
    [No Abstract]   [Full Text] [Related]  

  • 12. Coronavirus Vaccination Adverse Reactions and the Role of the Dermatologist.
    Pulsipher KJ; Presley CL; Waller JD; Szeto MD; Laughter MR; Dellavalle RP
    J Drugs Dermatol; 2021 Mar; 20(3):351-352. PubMed ID: 33683080
    [No Abstract]   [Full Text] [Related]  

  • 13. Could mixing COVID vaccines boost immune response?
    Ledford H
    Nature; 2021 Feb; 590(7846):375-376. PubMed ID: 33547431
    [No Abstract]   [Full Text] [Related]  

  • 14. Amid the cheering, some vaccines face questions.
    Cohen J
    Science; 2020 Dec; 370(6521):1151. PubMed ID: 33273083
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19 Vaccination and Obesity: Optimism and Challenges.
    Townsend MJ; Kyle TK; Stanford FC
    Obesity (Silver Spring); 2021 Apr; 29(4):634-635. PubMed ID: 33506642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA authorizes Johnson & Johnson COVID-19 vaccine.
    Med Lett Drugs Ther; 2021 Mar; 63(1620):41-42. PubMed ID: 33976088
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we need.
    Jin P; Li J; Pan H; Wu Y; Zhu F
    Signal Transduct Target Ther; 2021 Feb; 6(1):48. PubMed ID: 33531462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine.
    Dal-Ré R
    Vaccine; 2021 Feb; 39(8):1180-1182. PubMed ID: 33516602
    [No Abstract]   [Full Text] [Related]  

  • 19. Emergency Use Authorization of Covid Vaccines - Safety and Efficacy Follow-up Considerations.
    Krause PR; Gruber MF
    N Engl J Med; 2020 Nov; 383(19):e107. PubMed ID: 33064383
    [No Abstract]   [Full Text] [Related]  

  • 20. The US Regulatory System and COVID-19 Vaccines: The Importance of a Strong and Capable FDA.
    Sharfstein JM; Goodman JL; Borio L
    JAMA; 2021 Mar; 325(12):1153-1154. PubMed ID: 33587124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.